top of page

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Akash P. Kansagra, M.D. Manu S. Goyal, M.D. Washington University School of Medicine, St. Louis, MO kansagra@wustl.edu

Scott Hamilton, Ph.D. Gregory W. Albers, M.D. Stanford University, Stanford, CA


The effect of the Covid-19 pandemic on medical care for conditions other than Covid-19 has been difficult to quantify.1Any decrease in care for patients with acute conditions such as ischemic stroke may be consequential because timely treatment may decrease the incidence of disability


6 views0 comments

Recent Posts

See All

Comments


bottom of page